A double-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma

R. M. Cherniack, S. I. Wasserman, J. W. Ramsdell, J. C. Selner, J. W. Koepke, R. M. Rogers, G. R. Owens, E. M. Rubin, A. Wanner

Research output: Contribution to journalArticle

65 Scopus citations

Abstract

To determine the efficacy of nedocromil sodium in adult asthma patients using bronchodilators alone to control their disease, a consecutive sample of 127 patients with long-term asthma was studied for 16 weeks. The patients were maintained on sustained release theophylline preparations (SRT) and inhaled and oral beta-adrenergic bronchodilators (β2). One hundred sixteen patients (90 percent) completed the study; one placebo-treated patient withdrew owing to throat irradiation and wheezing. Nedocromil sodium provided an additional benefit to adult patients receiving SRT and inhaled β2-agonists. With the exception of night-time asthma, nedocromil sodium maintained this improvement for the final 12 weeks of the study despite a reduction in concomitant bronchodilator therapy.

Original languageEnglish (US)
Pages (from-to)1299-1306
Number of pages8
JournalCHEST
Volume97
Issue number6
DOIs
StatePublished - Jan 1 1990
Externally publishedYes

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'A double-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma'. Together they form a unique fingerprint.

  • Cite this

    Cherniack, R. M., Wasserman, S. I., Ramsdell, J. W., Selner, J. C., Koepke, J. W., Rogers, R. M., Owens, G. R., Rubin, E. M., & Wanner, A. (1990). A double-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma. CHEST, 97(6), 1299-1306. https://doi.org/10.1378/chest.97.6.1299